Australia markets closed

Greenwich LifeSciences, Inc. (GLSI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
13.05+0.16 (+1.24%)
As of 10:29AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-7,395
-8,892
-7,825
-4,571
-1,863
Depreciation & amortisation
3.612
3.612
3.612
3.612
3.609
Stock-based compensation
1,315
2,378
1,744
660.582
677.988
Change in working capital
-217.24
31.501
-122.267
-385.166
28.403
Accounts payable
-75
35.472
0
-526.732
-92.55
Other working capital
-6,294
-6,479
-6,200
-4,292
-1,153
Net cash provided by operating activities
-6,294
-6,479
-6,200
-4,292
-1,153
Cash flows from financing activities
Debt repayment
-
-
-
-
-360
Common stock issued
562.596
-
-
3,111
30,167
Common stock repurchased
0
0
-7,536
0
-
Other financing activities
-
-
-
-275.154
-360
Net cash used provided by (used for) financing activities
-6,974
0
-7,536
2,835
29,807
Net change in cash
-13,268
-6,479
-13,736
-1,456
28,654
Cash at beginning of period
28,906
13,468
27,204
28,660
6.835
Cash at end of period
15,638
6,989
13,468
27,204
28,660
Free cash flow
Operating cash flow
-6,294
-6,479
-6,200
-4,292
-1,153
Free cash flow
-6,294
-6,479
-6,200
-4,292
-1,153